1 Min Read
Sept 12 (Reuters) - IMPLANET SA:
* ANNOUNCES THAT IT HAS RECEIVED FDA CLEARANCE TO MARKET NEW JAZZ PASSER. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.